Lallemand Health Solutions closes major licensing deal with Proge Farm

Published: 4-Aug-2020

Deal has been agreed to commercialise Proge Farm's established probiotic strain for specific women's health benefits

Lallemand Health Solutions and Proge Farm have just closed a major licensing deal for the commercialisation by Lallemand Health Solutions of Proge Farm's established probiotic strain L. plantarum P17630 (Proge P17630), which has specific women's health benefits.

"Proge Farm highly documented probiotic strain L. plantarum P17630 (Proge P17630), is a valuable new asset in Lallemand Health Solution's Women's health probiotic range. Women's health is gaining more importance in the probiotics market as consumers are increasingly looking for natural ways to take care of their intimate health. Furthermore, with this specific strain, it will be even easier to do so with one daily dose taken orally," said Isabelle Champié, VP of Sales and Marketing at Lallemand.

"We are proud of this significant licensing commercialisation agreement with Lallemand Health Solutions, a worldwide renowned key player in the probiotics industry. They will have the ability to broadly disseminate our strain L. plantarum P17630 (Proge P17630); meaning more women will benefit from its compelling effect", said Giancarla Dondi, owner and CEO at Proge Farm.

Probiotics for women's health is a fast-growing niche as probiotics are seen as a natural alternative to the conventional solutions and women are willing to try them out especially when hit by reoccurring pains and infections, such as those associated with vaginal health (Lumina Intelligence).

"Once again, we have a demonstration that cooperation spells success. Within our teams as well as with our partners and customers, we achieve more together. Through our research and development, our innovation, our technical and manufacturing expertise, our commitment to quality, our ethics and passion, we keep enhancing lives in countless ways with probiotics." concluded Champié.

The licensing commercialisation agreement includes the following territories: Asia, Americas, France and Czech Republic.

Lallemand Health Solutions will launch this new offer in September at the Vitafoods Virtual Expo (September 7-11, 2020).

You may also like